Dr. Dooley is a Professor of Medicine and Addison B. Scoville Jr. Chair in Medicine; Director, Division of Infectious Diseases, Vanderbilt University Medical Center. Her research focuses on tuberculosis therapeutics with an emphasis on clinical trials of TB drugs and HIV/TB co-treatment, as well as clinical pharmacology of TB and HIV drugs. She is lead investigator for trials of therapeutics for drug-sensitive and drug-resistant TB, TB-HIV, and pediatric TB meningitis. She is on the TB scientific committees of the AIDS Clinical Trials Group and IMPAACT networks and is a consultant to World Health Organization on TB therapeutics and pharmacology. She maintains an active infectious diseases clinical practice.
